New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 16, 2014
08:02 EDTDYAXDyax names Todd Bazemore as Chief Commercial Officer
Dyax Corp. announced the appointment of Todd Bazemore as Executive Vice President and Chief Commercial Officer. Bazemore will be responsible for leading Dyax’s commercial organization which currently markets KALBITOR for the treatment of acute attacks of hereditary angioedema in patients 12 years of age and older. Bazemore most recently served as Vice President, Managed Markets at Sunovion Pharmaceuticals.
News For DYAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 14, 2014
16:23 EDTDYAXDyax files automatic mixed securities shelf
Subscribe for More Information
November 13, 2014
10:42 EDTDYAXSummer Street chief scientific officer holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use